Dysregulation of this system is mediated by increased TNF-α secretion, leading to daytime sleepiness, and disturbances in melatonin rhythms (including aberrancies and lower amplitudes), which disrupt sleep-wake cycles in AD patients with sleep disturbances. The gene discussed is TNF; the disease is Alzheimer disease.